PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Financial Results for quarter ended 30.06.2023 published in the newspapers on 14.08.2023. PANACEA BIOTEC LTD. - 531349 - Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Re-Classification From 'Promoter & Promoters' Group' Category To 'Public' Category Of Panacea Biotec Limited ('The Company')
The Board of Directors in its meeting held on August 12, 2023, analyzed and approved the request received from few shareholders who are presently part of the Promoters'' Group seeking reclassification of their respective name from "Promoters and Promoters Group" category to "Public category", based on confirmation received from them pursuant to provisions of Regulation 31A of SEBI LODR Regulations, subject to approval of stock exchanges and / or other approval, if any as may be required. PANACEA BIOTEC LTD. - 531349 - Unaudited Standalone And Consolidated Financial Results (Provisional) Of The Company For The Quarter Ended June 30, 2023
The Board of Directors in its meeting held on August 12, 2023, has considered and approved Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023. The meeting of the Board commenced at 11:30 A.M. and concluded at 3:00 P.M. PANACEA BIOTEC LTD. - 531349 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 12, 2023
The Board considered and approved following matters:- (i) Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company for quarter ended 30.06.2023; (ii) Revision in policy for determination of materiality of events and information and code of Conduct (iii) Date, time and venue of 39th Annual General Meeting - Friday, 29.09.2023 at 11:30 A.M (iv)Dates of Book Closure - 22.09.2023 to 29.09.2023 PANACEA BIOTEC LTD. - 531349 - Receipt Of Request Seeking Re-Classification From 'Promoter & Promoters' Group' Category To 'Public' Category Of Panacea Biotec Limited ('The Company')
We hereby inform you that the Company has received request letters on 09.08.2023 from few shareholders who are pesently part of the Promoters'' Group (each referred to as "Outgoing Promoter Group Member"), requesting to re-classify them from "Promoters and Promoters Group" category to "Public category, in accordance with the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 . PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During July, 2023 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith the data of shares dematerialised during the month of July, 2023 along with the copy of certificate obtained from Company''s RTA viz. Skyline Financial Services Pvt. Ltd. in this regard. PANACEA BIOTEC LTD. - 531349 - Intimation Regarding Resignation Of Senior Management Personnel Of The Company'S Material Subsidiary Viz. Panacea Biotec Pharma Limited
We would like to inform you that Mr. Neeraj Joshi, President - Sales & Marketing International Pharma & Vaccine India Business of the Company''s material subsidiary, Panacea Biotec Pharma Ltd. has vide email dated 15.07.2023 tendered his resignation in order to pursue career advancement as a progressive change to further enhance his skills. Material Subsidiary has accepted his resignation and has relieved him from duties w.e..f close of business hours of 31.07.2023. Disclosure pursuant to SEBI Circular dated 13.07.2023, with regard to change in Senior Management Personnel is attached herewith. PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter Ended June 30, 2023
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30, 2023. PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During June, 2023
We would like to inform you that no share has been dematerialised during the month of June, 2023. A copy of the certificate obtained from the Company''s RTA viz. Skyline Financial Services Pvt. Ltd. regarding shares dematerialised on June 30, 2023 is enclosed herewith. PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a certificate dated July 04, 2023, issued by Skyline Financial Services Pvt Ltd, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2023.